{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:13:41Z","timestamp":1777961621281,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/bjc.2015.470","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:33:14Z","timestamp":1455841994000},"page":"524-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma"],"prefix":"10.1038","volume":"114","author":[{"given":"Steven C","family":"Kao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela B","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjaak","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiny","family":"Korse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Vallely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"issue":"3","key":"BFbjc2015470_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/path.4535","volume":"236","author":"M Bellenghi","year":"2015","unstructured":"Bellenghi M, Puglisi R, Pedini F, De Feo A, Felicetti F, Bottero L, Sangaletti S, Errico MC, Petrini M, Gesumundo C, Denaro M, Felli N, Pasquini L, Tripodo C, Colombo MP, Care A, Mattia G (2015) SCD5-induced oleic acid production reduces malanoma malignancy by intracellular retention of SPARC and cathepsin B. J Pathol 236 (3): 315\u2013325.","journal-title":"J Pathol"},{"issue":"1","key":"BFbjc2015470_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1559-0275-10-16","volume":"10","author":"F Cerciello","year":"2013","unstructured":"Cerciello F, Choi M, Nicastri A, Bausch-Fluck D, Ziegler A, Vitek O, Felley-Bosco E, Stahel R, Aebersold R, Wollscheid B (2013) Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clin Proteomics 10 (1): 16.","journal-title":"Clin Proteomics"},{"issue":"1","key":"BFbjc2015470_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semcdb.2009.11.018","volume":"21","author":"A Chlenski","year":"2010","unstructured":"Chlenski A, Cohn S (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21 (1): 55\u201365.","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"BFbjc2015470_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ijc.21357","volume":"118","author":"A Chlenski","year":"2006","unstructured":"Chlenski A, Liu S, Guerrero L, Yang Q, Tian Y, Salwen H, Zage P, Cohn S (2006) SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer 118 (2): 310\u2013316.","journal-title":"Int J Cancer"},{"issue":"46","key":"BFbjc2015470_CR5","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/onc.2013.476","volume":"33","author":"M Cioce","year":"2014","unstructured":"Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi M, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce C, Pass H, Blandino G (2014) Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene 33 (46): 5319\u20135331.","journal-title":"Oncogene"},{"issue":"10","key":"BFbjc2015470_CR6","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ijc.27518","volume":"131","author":"K Edlund","year":"2012","unstructured":"Edlund K, Lindskog C, Saito A, Berglund A, Ponten F, Goransson-Kultima H, Isaksson A, Jirstrom K, Planck M, Johansson L, Lambe M, Homberg L, Nyberg F, Ekman S, Berggvist M, Landelius P, Lamberg K, Botling J, Ostman A, Micke P (2012) CD99 is a novel prognostic stromal marker in non-small cell lung cancer. Int J Cancer 131 (10): 2264\u20132273.","journal-title":"Int J Cancer"},{"issue":"10","key":"BFbjc2015470_CR7","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang LY, Zhang J (2004) Bioconductor: open software development for computational biopsy and bioinformatics. Genome Biol 5 (10): R80.","journal-title":"Genome Biol"},{"issue":"10","key":"BFbjc2015470_CR8","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","volume":"13","author":"B-D Grigoriu","year":"2007","unstructured":"Grigoriu B-D, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Gregoire M, Porte H, Copin M-C, Lassalle P (2007) Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 13 (10): 2928\u20132935.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"BFbjc2015470_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jcb.240490310","volume":"49","author":"P Hasselaar","year":"1992","unstructured":"Hasselaar P, Sage EH (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49 (3): 272\u2013283.","journal-title":"J Cell Biochem"},{"issue":"11","key":"BFbjc2015470_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.5732\/cjc.011.10377","volume":"31","author":"Y Huang","year":"2012","unstructured":"Huang Y, Zhang J, Zhao Y, Jiang W, Xue C, Xu F, Zhao H, Zhang Y, Zhao L, Hu Z, Yao Z, Liu Q, Zhang L (2012) SPARC expression and prognostic value in non-small cell lung cancer. Chin J Cancer 31 (11): 541\u2013548.","journal-title":"Chin J Cancer"},{"issue":"11","key":"BFbjc2015470_CR11","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1039\/c1mb05236e","volume":"7","author":"L Jankova","year":"2011","unstructured":"Jankova L, Chan C, Fung CL, Song X, Kwun SY, Cowley MJ, Kaplan W, Dent OF, Bokey EL, Chapuis PH, Baker MS, Robertson GR, Clarke SJ, Molloy MP (2011) Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry. Mol Biosyst 7 (11): 2997\u20133005.","journal-title":"Mol Biosyst"},{"issue":"4","key":"BFbjc2015470_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/path.4377","volume":"233","author":"L Jiang","year":"2014","unstructured":"Jiang L, Yamashita Y, Chew S, Akatsuka S, Ukai S, Wang S, Nagai H, Okazaki Y, Takahashi T, Toyokuni S (2014) Connective tissue growth factor and \u03b2-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma. J Pathol 233 (4): 402\u2013414.","journal-title":"J Pathol"},{"issue":"4","key":"BFbjc2015470_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/PAT.0b013e328342016c","volume":"43","author":"S Kao","year":"2011","unstructured":"Kao S, Lee K, Armstrong N, Clarke S, Vardy J, Van Zandwijk N, Reid G, Burn J, McCaughan B, Henderson D, Klebe S (2011) Validation of tissue microarray technology in malignant pleural mesotheloma. Pathology 43 (4): 128\u2013132.","journal-title":"Pathology"},{"issue":"2","key":"BFbjc2015470_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.lungcan.2011.06.007","volume":"75","author":"S Kao","year":"2012","unstructured":"Kao S, Harvie R, Paturi F, Taylor R, Davey R, Abraham R, Clarke S, Marx G, Cullen M, Kerestes Z, Pavlakis N (2012) The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone orcombined with cisplatin\/gemcitabine. Lung Cancer 75 (2): 248\u2013254.","journal-title":"Lung Cancer"},{"issue":"6","key":"BFbjc2015470_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/bjc.2015.286","volume":"113","author":"M Kirschner","year":"2015","unstructured":"Kirschner M, Pulford E, Mir Hoda A, Rozsas A, Griggs K, Cheng Y, Edelman J, Kao S, Hyland R, Dong Y, Laszlo V, Klikovits T, Vallely M, Grusch M, Hegedus B, Dome B, Klepetko W, Van Zandwijk N, Klebe S, Reid G (2015) Fibulin-3 has a potential prognostic, but not diagnostic role in malignant pleural mesothelioma. Br J Cancer 113 (6): 963\u2013969.","journal-title":"Br J Cancer"},{"issue":"17","key":"BFbjc2015470_CR16","first-page":"5376","volume":"63","author":"M Koukourakis","year":"2003","unstructured":"Koukourakis M, Giatromanolaki A, Brekken R, Sivridis E, Gatter K, Harris A, Sage E (2003) Enhanced expression of SPARC\/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia\/acidity and with poor prognosis of patients. Cancer Res 63 (17): 5376\u20135380.","journal-title":"Cancer Res"},{"issue":"6","key":"BFbjc2015470_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1158\/1535-7163.MCT-13-0065","volume":"12","author":"K Kryeziu","year":"2013","unstructured":"Kryeziu K, Jungwirth U, Hoda M, Ferk F, Knasmuller S, Karnthaler-Benbakka C, Kowol C, Berger W, Heffeter P (2013) Synergistic anticancer activity of arsenic trioxide with erlotiib is based on inhibition of EGFR-mediated DNA double-strand break repair. Mol Cancer Ther 12 (6): 1073\u20131084.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"BFbjc2015470_CR18","doi-asserted-by":"publisher","first-page":"e54652","DOI":"10.1371\/journal.pone.0054652","volume":"8","author":"H Lee","year":"2013","unstructured":"Lee H, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson L, Mikkelsen T, Slavin S, Jacoby E, Yalon M, Toren A, Rempel S, Brodie C (2013) MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One 8 (2): e54652.","journal-title":"PLoS One"},{"issue":"2","key":"BFbjc2015470_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/bjc.2013.731","volume":"110","author":"A Linton","year":"2014","unstructured":"Linton A, Cheng Y, Griggs K, Kirschner M, Gattani S, Srikaran S, Kao S, McCaughan B, Klebe S, Van Zandwijk N, Reid G (2014) An RNAi-based screen reveals PKL1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. Br J Cancer 110 (2): 510\u2013519.","journal-title":"Br J Cancer"},{"issue":"36","key":"BFbjc2015470_CR20","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23 (36): 9067\u20139072.","journal-title":"J Clin Oncol"},{"issue":"3-4","key":"BFbjc2015470_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10555-013-9439-3","volume":"32","author":"C Neuzillet","year":"2013","unstructured":"Neuzillet C, Tijeras-Raballand A, Cros J, Faivre S, Hammel P, Raymond E (2013) Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer Metastasis Rev 32 (3-4): 585\u2013602.","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"BFbjc2015470_CR22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/onc.2011.312","volume":"31","author":"B Orr","year":"2012","unstructured":"Orr B, Riddick A, Stewart G, Anderson R, Franco O, Hayward S, Thomson A (2012) Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 31 (9): 1130\u20131142.","journal-title":"Oncogene"},{"issue":"10","key":"BFbjc2015470_CR23","doi-asserted-by":"publisher","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","volume":"7","author":"R Ostroff","year":"2012","unstructured":"Ostroff R, Mehan M, Stewart A, Ayers D, Brody E, Williams S, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass H (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One 7 (10): e46091.","journal-title":"PLoS One"},{"issue":"15","key":"BFbjc2015470_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","volume":"367","author":"H Pass","year":"2012","unstructured":"Pass H, Levin S, Harbut M, Melamed J, Chirboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman G, Thornquist M, Liu G, De Perrot M, Tsao M, Goparaju C (2012) Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 367 (15): 1417\u20131427.","journal-title":"N Engl J Med"},{"key":"BFbjc2015470_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2014.02.006","volume":"25","author":"J Paulsson","year":"2014","unstructured":"Paulsson J, Micke P (2014) Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol 25: 61\u201368.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"BFbjc2015470_CR26","doi-asserted-by":"publisher","first-page":"e58132","DOI":"10.1371\/journal.pone.0058132","volume":"8","author":"V Relan","year":"2013","unstructured":"Relan V, Morrison L, Parsonson K, Clarke B, Duhig E, Windsor M, Mater K, Naidoo R, Passmore L, Mccaul E, Courtney D, Yang I, Fong K, Bowman R (2013) Phenotypes and karyotypes of human malignant mesothelioma cell lines. PLoS One 8 (3): e58132.","journal-title":"PLoS One"},{"issue":"2","key":"BFbjc2015470_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.lungcan.2007.12.025","volume":"61","author":"O Roe","year":"2008","unstructured":"Roe O, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen T, Robinson BWS, Kjaerheim K (2008) Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer 61 (2): 235\u2013243.","journal-title":"Lung Cancer"},{"issue":"12","key":"BFbjc2015470_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"P Ross","year":"2004","unstructured":"Ross P, Huang Y, Marchese J, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin D (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3 (12): 1154\u20131169.","journal-title":"Mol Cell Proteomics"},{"issue":"21","key":"BFbjc2015470_CR29","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1158\/0008-5472.CAN-08-1327","volume":"68","author":"S Sangaletti","year":"2008","unstructured":"Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C, Colombo MP (2008) Macrophage-derived SPARC bridges tumor cell-extraceullar matrix interactions toward metastasis. Cancer Res 68 (21): 9050\u20139059.","journal-title":"Cancer Res"},{"issue":"32","key":"BFbjc2015470_CR30","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1038\/sj.onc.1206807","volume":"22","author":"N Sato","year":"2003","unstructured":"Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M (2003) SPARC\/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 22 (32): 5021\u20135030.","journal-title":"Oncogene"},{"issue":"3","key":"BFbjc2015470_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, De Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Pechoux C, Mutti L, Pairon J-C, Stahel R, Van Houtte P, Van Meerbeeck J, Waller D, Weder W (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. Eur Respir J 35 (3): 479\u2013495.","journal-title":"Eur Respir J"},{"issue":"2","key":"BFbjc2015470_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ijc.2910510220","volume":"51","author":"D Schmitter","year":"1992","unstructured":"Schmitter D, Lauber B, Fagg B, Stahel R (1992) Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int J Cancer 51 (2): 296\u2013301.","journal-title":"Int J Cancer"},{"issue":"12","key":"BFbjc2015470_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/JTO.0b013e318187491c","volume":"3","author":"J Schneider","year":"2008","unstructured":"Schneider J, Hoffmann H, Dienemann H, Herth F, Meister M, Muley T (2008) Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer. J Thorac Oncol 3 (12): 1317\u20131324.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"BFbjc2015470_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/annonc\/mdu084","volume":"25","author":"M Sinn","year":"2014","unstructured":"Sinn M, Sinn B, Striefler J, Lindner J, Stieler J, Lohneis P, Bischoff S, Blaker H, Pelzer U, Bahra M, Dietel M, Dorken B, Oettle H, Riess H, Denkert C (2014) SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Ann Oncol 25 (5): 1025\u20131032.","journal-title":"Ann Oncol"},{"issue":"7","key":"BFbjc2015470_CR35","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1021\/pr800072x","volume":"7","author":"X Song","year":"2008","unstructured":"Song X, Bandow J, Sherman J, Baker JD, Brown PW, McDowell MT et al (2008) iTRAQ experimental design for plasma biomarker discovery. J Proteome Res 7 (7): 2952\u20132958.","journal-title":"J Proteome Res"},{"issue":"6","key":"BFbjc2015470_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","volume":"11","author":"I Tai","year":"2008","unstructured":"Tai I, Tang M (2008) SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 11 (6): 231\u2013246.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"BFbjc2015470_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","volume":"78","author":"J Van Meerbeeck","year":"2011","unstructured":"Van Meerbeeck J, Scherpereel A, Surmont V, Baas P (2011) Malignant pleural mesothelioma: the standard of care and challenges for future management. Crit Rev Oncol Hematol 78 (2): 92\u2013111.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9625","key":"BFbjc2015470_CR38","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(08)60703-5","volume":"371","author":"NJ Vogelzang","year":"2008","unstructured":"Vogelzang NJ (2008) Chemotherapy for malignant pleural mesothelioma. The Lancet 371 (9625): 1640\u20131642.","journal-title":"The Lancet"},{"issue":"14","key":"BFbjc2015470_CR39","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (14): 2636\u20132644.","journal-title":"J Clin Oncol"},{"issue":"34","key":"BFbjc2015470_CR40","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1200\/JCO.2011.36.5742","volume":"29","author":"D Von Hoff","year":"2011","unstructured":"Von Hoff D, Ramanathan R, Borad M, Laheru D, Smith L, Wood T, Korn R, Desai N, Trieu V, Iglesias J, Zhang H, Soon-Shiong P, Shi T, Rajeshkumar N, Maitra A, Hidalgo M (2011) Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I\/II trial. J Clin Oncol 29 (34): 4548\u20134554.","journal-title":"J Clin Oncol"},{"issue":"5","key":"BFbjc2015470_CR41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.5114\/aoms.2014.46207","volume":"10","author":"Z Wang","year":"2014","unstructured":"Wang Z, Hao B, Yang Y, Wang R, Li Y, Wu Q (2014) Prognostic role of SPARC expression in gastric cancer: a meta-analysis. Arch Med Sci 10 (5): 863\u2013869.","journal-title":"Arch Med Sci"},{"issue":"3 Pt 2","key":"BFbjc2015470_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(82)90324-5","volume":"31","author":"Y Wu","year":"1982","unstructured":"Wu Y, Parker L, Binder N, Beckett M, Sinard J, Griffiths C, Rheinwald J (1982) The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31 (3 Pt 2): 693\u2013703.","journal-title":"Cell"},{"key":"BFbjc2015470_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1756-9966-29-59","volume":"29","author":"J Yin","year":"2010","unstructured":"Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, Wang X, Zhu J, Gao H (2010) Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res 29: 59.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015470","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:31:32Z","timestamp":1684416692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFbjc2015470"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.470","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]},"assertion":[{"value":"27 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}